VAXX logo

Vaxxinity (VAXX) Company Overview

Profile

Full Name:

Vaxxinity, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

November 11, 2021

Indexes:

Not included

Description:

VAXX (Vaxxinity) is a biotechnology company focused on developing innovative vaccines. They aim to create affordable and effective solutions for various diseases, using advanced technology to enhance immune responses. Their mission is to improve global health through accessible vaccination options.

Events Calendar

Earnings

Next earnings date:

Feb 7, 2025

Recent quarterly earnings:

Mar 27, 2024

Recent annual earnings:

Mar 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Sep 8, 23 Baird
Outperform
Apr 27, 22 Evercore ISI Group
In-Line
Dec 7, 21 Jefferies
Buy
Dec 6, 21 B of A Securities
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Vaxxinity UB-312 Parkinson's Trial Results Published in Nature Medicine
Vaxxinity UB-312 Parkinson's Trial Results Published in Nature Medicine
Vaxxinity UB-312 Parkinson's Trial Results Published in Nature Medicine
VAXX
globenewswire.comJune 20, 2024

UB-312 is the first Parkinson's candidate to reduce pathology as measured by a seed amplification assay, and suggest clinical improvement on motor experiences of daily living.

Why Is Vaxxinity (VAXX) Stock Up 39% Today?
Why Is Vaxxinity (VAXX) Stock Up 39% Today?
Why Is Vaxxinity (VAXX) Stock Up 39% Today?
VAXX
InvestorPlaceMay 3, 2024

Vaxxinity stock is experiencing a rise on Friday with significant pre-market trading activity, with over 21 million shares being traded at the moment.

Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting
Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting
Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting
VAXX
GlobeNewsWireMarch 28, 2024

Presentation will address the Company's clinical data in Parkinson's disease Presentation will address the Company's clinical data in Parkinson's disease

Vaxxinity to Present at Upcoming November Medical and Investor Conferences
Vaxxinity to Present at Upcoming November Medical and Investor Conferences
Vaxxinity to Present at Upcoming November Medical and Investor Conferences
VAXX
GlobeNewsWireNovember 13, 2023

CAPE CANAVERAL, Fla., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of medicines, today announced that its scientists and executives will present and participate in meetings at three upcoming medical and investor conferences in November.

Down -22.18% in 4 Weeks, Here's Why You Should You Buy the Dip in Vaxxinity, Inc. (VAXX)
Down -22.18% in 4 Weeks, Here's Why You Should You Buy the Dip in Vaxxinity, Inc. (VAXX)
Down -22.18% in 4 Weeks, Here's Why You Should You Buy the Dip in Vaxxinity, Inc. (VAXX)
VAXX
Zacks Investment ResearchSeptember 7, 2023

The heavy selling pressure might have exhausted for Vaxxinity, Inc. (VAXX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Vaxxinity to Present at World Vaccine Congress, American Academy of Neurology, and BNA2023 Festival of Neuroscience in April
Vaxxinity to Present at World Vaccine Congress, American Academy of Neurology, and BNA2023 Festival of Neuroscience in April
Vaxxinity to Present at World Vaccine Congress, American Academy of Neurology, and BNA2023 Festival of Neuroscience in April
VAXX
GlobeNewsWireMarch 28, 2023

Vaxxinity CEO Mei Mei Hu to participate in fireside chat with Sarah Despres, Counselor to the Secretary for Public Health and Science, U.S. Department of Health and Human Services, at World Vaccine Congress

FAQ

  • What is the ticker symbol for Vaxxinity?
  • Does Vaxxinity pay dividends?
  • What sector is Vaxxinity in?
  • What industry is Vaxxinity in?
  • What country is Vaxxinity based in?
  • When did Vaxxinity go public?
  • Is Vaxxinity in the S&P 500?
  • Is Vaxxinity in the NASDAQ 100?
  • Is Vaxxinity in the Dow Jones?
  • When was Vaxxinity's last earnings report?
  • When does Vaxxinity report earnings?
  • Should I buy Vaxxinity stock now?

What is the ticker symbol for Vaxxinity?

The ticker symbol for Vaxxinity is NASDAQ:VAXX

Does Vaxxinity pay dividends?

No, Vaxxinity does not pay dividends

What sector is Vaxxinity in?

Vaxxinity is in the Healthcare sector

What industry is Vaxxinity in?

Vaxxinity is in the Biotechnology industry

What country is Vaxxinity based in?

Vaxxinity is headquartered in United States

When did Vaxxinity go public?

Vaxxinity's initial public offering (IPO) was on November 11, 2021

Is Vaxxinity in the S&P 500?

No, Vaxxinity is not included in the S&P 500 index

Is Vaxxinity in the NASDAQ 100?

No, Vaxxinity is not included in the NASDAQ 100 index

Is Vaxxinity in the Dow Jones?

No, Vaxxinity is not included in the Dow Jones index

When was Vaxxinity's last earnings report?

Vaxxinity's most recent earnings report was on Mar 27, 2024

When does Vaxxinity report earnings?

The next expected earnings date for Vaxxinity is Feb 7, 2025

Should I buy Vaxxinity stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions